agilon health (NYSE:AGL) Trading Down 6.1%

agilon health, inc. (NYSE:AGL)’s share price traded down 6.1% on Monday . The stock traded as low as $4.61 and last traded at $4.65. 722,891 shares changed hands during trading, a decline of 88% from the average session volume of 5,811,970 shares. The stock had previously closed at $4.95.

Analyst Ratings Changes

A number of research firms recently commented on AGL. Barclays initiated coverage on shares of agilon health in a research note on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price objective on the stock. Benchmark reduced their target price on shares of agilon health from $13.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. JPMorgan Chase & Co. downgraded shares of agilon health from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $17.00 to $9.00 in a report on Friday, January 5th. Stifel Nicolaus decreased their price target on shares of agilon health from $10.00 to $9.00 and set a “hold” rating for the company in a report on Thursday, February 22nd. Finally, Leerink Partnrs lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $9.73.

agilon health Price Performance

The stock has a market cap of $1.83 billion, a price-to-earnings ratio of -6.88 and a beta of 0.49. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05. The company’s 50-day moving average is $5.85 and its 200-day moving average is $10.11.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.13). The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The company’s quarterly revenue was up 71.8% on a year-over-year basis. During the same period in the previous year, the company posted ($0.14) earnings per share. Equities research analysts expect that agilon health, inc. will post -0.35 earnings per share for the current fiscal year.

Institutional Investors Weigh In On agilon health

Hedge funds have recently made changes to their positions in the company. CWM LLC lifted its holdings in agilon health by 83.7% during the 3rd quarter. CWM LLC now owns 1,585 shares of the company’s stock worth $28,000 after buying an additional 722 shares in the last quarter. Signaturefd LLC lifted its stake in shares of agilon health by 73.7% during the third quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock valued at $30,000 after acquiring an additional 710 shares during the period. First Horizon Advisors Inc. increased its position in agilon health by 41.2% in the first quarter. First Horizon Advisors Inc. now owns 1,553 shares of the company’s stock worth $37,000 after purchasing an additional 453 shares during the period. Ronald Blue Trust Inc. acquired a new stake in agilon health in the third quarter worth about $38,000. Finally, Quest Partners LLC acquired a new position in agilon health during the 4th quarter valued at about $45,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.